Lymphomatoid granulomatosis laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of Lymphomatoid granulomatosis include [[Complete blood count|CBC]], [[Erythrocyte sedimentation rate|ESR]], [[Hematocrit | Laboratory findings consistent with the diagnosis of Lymphomatoid granulomatosis include [[Complete blood count|CBC]], [[Erythrocyte sedimentation rate|ESR]], and [[Hematocrit]]. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Latest revision as of 21:27, 18 December 2018
|
Lymphomatoid granulomatosis Microchapters |
|
Differentiating Lymphomatoid granulomatosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphomatoid granulomatosis laboratory tests On the Web |
|
American Roentgen Ray Society Images of Lymphomatoid granulomatosis laboratory tests |
|
Directions to Hospitals Treating Lymphomatoid granulomatosis |
|
Risk calculators and risk factors for Lymphomatoid granulomatosis laboratory tests |
Overview
Laboratory findings consistent with the diagnosis of Lymphomatoid granulomatosis include CBC, ESR, and Hematocrit.
Laboratory Findings
Laboratory findings consistent with the diagnosis of Lymphomatoid granulomatosis include:[1][2][3]
- CBC
- Leukopenia
- Lymphopenia
- Low CD4 count
- Leukocytosis is rare
- Elevated Hematocrit
- ESR
- Can be moderately elevated or normal
- Lack of anergy
References
- ↑ Liebow, Averill A.; Carrington, Charles R.B.; Friedman, Paul J. (1972). "Lymphomatoid granulomatosis". Human Pathology. 3 (4): 457–558. doi:10.1016/S0046-8177(72)80005-4. ISSN 0046-8177.
- ↑ Katzenstein AL, Carrington CB, Liebow AA (1979). "Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases". Cancer. 43 (1): 360–73. PMID 761171.
- ↑ Sordillo PP, Epremian B, Koziner B, Lacher M, Lieberman P (1982). "Lymphomatoid granulomatosis: an analysis of clinical and immunologic characteristics". Cancer. 49 (10): 2070–6. PMID 6978760.